GDPD2 Antikörper (AA 210-255) (FITC)
-
- Target Alle GDPD2 Antikörper anzeigen
- GDPD2 (glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2))
-
Bindungsspezifität
- AA 210-255
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GDPD2 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human GDPD2/GDE3
- Isotyp
- IgG
- Top Product
- Discover our top product GDPD2 Primärantikörper
-
anti-glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2) (AA 210-490) antibody
GDPD2 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2) antibodyGDPD2 Reaktivität: Human, Maus IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2) (AA 210-255) antibodyGDPD2 Reaktivität: Human, Maus, Ratte WB, IF (p), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2) (AA 305-334) antibodyGDPD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB38460 unconjugated
anti-glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2) (AA 1-539) antibodyGDPD2 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
- IF(IHC-P) 1:50-200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- GDPD2 (glycerophosphodiester phosphodiesterase Domain Containing 2 (GDPD2))
- Andere Bezeichnung
- GDE3 (GDPD2 Produkte)
- Hintergrund
-
Synonyms: GDE3, OBDPF, Glycerophosphoinositol inositolphosphodiesterase GDPD2, Glycerophosphodiester phosphodiesterase 3, Glycerophosphodiester phosphodiesterase domain-containing protein 2, Osteoblast differentiation promoting factor, GDPD2, UNQ1935/PRO4418
Background: Has glycerophosphoinositol inositolphosphodiesterase activity and specifically hydrolyzes glycerophosphoinositol, with no activity for other substrates such as glycerophosphoinositol 4-phosphate, glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. Accelerates the program of osteoblast differentiation and growth. May play a role in remodeling of the actin cytoskeleton (By similarity).
- Gen-ID
- 54857
- UniProt
- Q9HCC8
-
